Canadian Journal of Physiology and Pharmacology · 2016 · 64 citations · 39 references
MedicineNeurologyNeuroscienceNeurorehabilitationPhysical ActivityRehabilitationNeurological Physical TherapyNeurological RehabilitationNeuromuscular RehabilitationParkinson DiseaseParkinson Disease RehabilitationParkinsonian Disorders6-Minute Walk TestClinical SymptomsExtrapyramidal SignsExtrapyramidal SystemMotor RehabilitationParkinson's Disease RehabilitationParkinson’s Disease RehabilitationRehabilitation Training
Increasing evidence suggests that motor rehabilitation may delay Parkinson's disease (PD) progression. Moreover, parallel treatments in animals up-regulate brain-derived neurotrophic factor (BDNF). Thus, we investigated the effect of a motor rehabilitation protocol on PD symptoms and BDNF serum levels. Motor rehabilitation training consisted of a cycle of 20 days/month of physiotherapy divided in 3 daily sessions. Clinical data were collected at the beginning, at the end, and at 90 days follow-up. BDNF serum levels were detected by ELISA at 0, 7, 14, 21, 30, and 90 days. The follow-up period had a duration of 60 days (T30-T90). The results showed that at the end of the treatment (day 30), an improvement in extrapyramidal signs (UPDRS III; UPDRS III - Gait and Balance items), motor (6 Minute Walking Test), and daily living activities (UPDRS II; PDQ-39) was observed. BDNF levels were increased at day 7 as compared with baseline. After that, no changes in BDNF were observed during the treatment and in the successive follow-up. This study demonstrates that motor rehabilitation training is able to ameliorate PD symptoms and to increase temporarily BDNF serum levels. The latter effect may potentially contribute to the therapeutic action.
39
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 86.9K citations
Christopher G. Goetz, Werner Poewe, Olivier Rascol et al. · Movement Disorders · 2004 · 2.3K citations
Medicine, Neurology, Neuroscience +17
BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra
Carolyn Hyman, Magdalena Hofer, Yves‐Alain Barde et al. · Nature · 1991 · 1.5K citations
Transport of brain-derived neurotrophic factor across the blood–brain barrier
Weihong Pan, William A. Banks, Melita B. Fasold et al. · Neuropharmacology · 1998 · 1.3K citations